⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
cGAS–STING DNA Sensing
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-10 — The neuro-inflammaging triangle: a self-amplifying circuit of protein pathology, senescence-associated secretory phenotype and innate immunity in neurodegenerative disease.: [expert-opinion] Review, no new primary data: incorporates cGAS–STING alongside NLRP3 into the innate danger-sensing arm of a proposed protein pathology–senescence/SASP feedback circuit, without establishing pathway necessity across neurodegenerative diseases or human efficacy of combined pathway targeting. [expert-opinion] (novelty: 3)
- 2026-10-10 — THE AGING PURINOME: A PURINERGIC FRAMEWORK LINKING THE HALLMARKS OF AGING TO INFLAMMAGING.: cross-connection with aging-purinome: The purinome framework places extracellular nucleotide/nucleoside dysregulation alongside cytosolic nucleic-acid sensing as parallel nucleotide-economy inputs to sterile inflammation in aging. (novelty: 3)
- 2026-07-17 — Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer’s and Parkinson’s disease.: 2026 Urolithin A neuro-nutraceutical review cites preclinical evidence that UA dampens neuroinflammation partly via reduced mtDNA leakage and attenuated cGAS–STING/NLRP3 signaling in microglia, extending the mitophagy-failure → DNA-sensing → neuroinflammation axis into AD/PD contexts — narrative framing, no new sensing assays. [expert-opinion] (novelty: 3)
- 2026-10-06 — Multimodal Technology-Driven aging Research: Decoding the Mitochondria‒Pyroptosis axis in muscle atrophy and cognitive decline.: 2026 methodological review positions oxidized cytosolic mtDNA as a shared upstream ligand feeding both cGAS–STING and NLRP3 inflammasome activation within a proposed mitochondria–pyroptosis axis in sarcopenia and cognitive decline — synthesis, no new DNA-sensing measurements. [expert-opinion] (novelty: 3)
- 2026-09-14 — MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.: Gaucher disease mouse and patient-iPSC study: MA-5 blocks mtDNA-driven cGAS–STING activation (and downstream NLRP3) in microglia by restoring mitochondrial cristae, extending the mtDNA→cGAS–STING inflammaging axis into a monogenic lysosomal-storage/neurodegenerative context and adding a mitochondria-cristae-directed compound to the upstream-lever roster. [animal-model] (novelty: 3)
- 2026-05-15 — Jintiange ameliorates age-related sarcopenia by inhibiting the cGAS-STING signaling pathway via maintaining mitochondrial homeostasis.: 2026 aged-mouse study: oral Jintiange (a clinically available TCM tiger-bone substitute) suppresses skeletal-muscle cGAS–STING/NF-κB signaling by limiting mtDNA leakage, ameliorating age-related sarcopenia with benefits persisting after withdrawal — extends the mtDNA→cGAS–STING axis into aging muscle and adds a compound-level upstream lever. [animal-model] (novelty: 3)
- 2026-09-10 — NAD+ Metabolic Reprogramming Drives CD8+ T Cells Senescence and Exacerbates Ulcerative Colitis: cross-connection with immunosenescence: CD8 T-cell senescence in this UC model is driven by mtDNA release engaging cGAS–STING, extending the DNA-sensing → immunosenescence link (previously anchored in the macrophage Lamtor5 axis) into an adaptive-immune, T-cell-intrinsic context. (novelty: 3)
- 2026-09-01 — NADMetabolic Reprogramming Drives CD8T Cells Senescence and Exacerbates Ulcerative Colitis.: 2026 UC study: NAD-depletion-driven mitochondrial dysfunction releases mtDNA that activates cGAS–STING in CD8 T cells, driving their senescence and exacerbating colitis; extends the mtDNA–cGAS–STING senescence axis into an adaptive-immune (CD8 T cell) compartment and a human IBD context. [animal-model] (novelty: 3)
- 2026-06-27 — Co-exposure to environmental lead and hypertension exacerbates anxiety and depression via mtDNA-mediated cGAS phase separation.: 2026 mouse study: cytosolic mtDNA released under combined lead + hypertension exposure drives cGAS liquid-liquid phase separation in prefrontal astrocytes, coupling mtDNA sensing biophysics (not just enzymatic activation) to a downstream senescence/behavioral phenotype. [animal-model] (novelty: 3)
- 2026-07-01 — AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies.: cross-connection with nuclear-lamina-progerin: LMNA-driven progeroid pathology (both R527C and HGPS-style progerin) converges on cGAS–STING-mediated inflammation as a senescence trigger, positioning progerin-lowering ASOs and DNA-sensing blockade as parallel upstream interventions. (novelty: 4)
- 2026-07-16 — Age-associated decline of Lamtor5 drives immunosenescence and systemic aging via cGAS-mediated paracrine inflammation.: 2026 mouse study: age-related Lamtor5 decline impairs ESCRT-mediated lysosomal degradation of cGAS in macrophages, causing cGAS accumulation and paracrine cGAS–STING-driven inflammation; macrophage-targeted cGAS blockade or senolytics rescue aging phenotypes — extends cGAS regulation beyond ligand supply to a proteostatic clearance node in tissue macrophages. [animal-model] (novelty: 3)
- 2026-07-17 — Manganese overload as a previously underappreciated trigger of cellular senescence: Unraveling mechanisms and therapeutic rescue by the senolytic quercetin.: 2026 C. elegans + PC12 study: manganese overload engages STING-related signaling as part of a multi-hallmark senescence program (alongside telomere attrition and mtDNA-relevant mitochondrial dysfunction), extending environmental-metal exposure into the DNA-sensing–senescence axis; quercetin partially attenuates the response. [animal-model] (novelty: 3)
- 2026-08-18 — Spatial niche remodeling of senescent liver-resident immune cells and its role in chronic liver diseases.: 2026 hepatic immune-senescence review nominates mtDNA–cGAS–STING as the effector arm of the SASP in liver-resident macrophages and lymphocytes during chronic liver disease progression, extending the DNA-sensing–SASP link into hepatic niche remodeling — synthesis, no new sensing data. [expert-opinion] (novelty: 3)
- 2026-09-08 — LAPTM5 correlates with RPE senescence and subretinal fibrosis through the LAPTM5-WWP2-OPTN mitophagy cascade and cGAS/STING activation in a D-galactose-induced aging model.: 2026 D-gal RPE study places cGAS–STING downstream of LAPTM5–WWP2–OPTN mitophagy failure as the effector of RPE senescence and subretinal fibrosis, with pharmacological STING inhibition rescuing fibrotic lesions in vivo — extends STING-driven aging pathology into the outer retina. [animal-model] (novelty: 3)
- 2026-06-24 — Mitochondrial transcription factor A: linking mtDNA maintenance, mitochondrial stress responses, and inflammaging.: 2026 TFAM review nominates TFAM stoichiometric imbalance as a proximal source of cytosolic mtDNA ligands for cGAS–STING, extending the DNA-sensing substrate repertoire beyond nuclear chromatin fragments and retroelements to mitochondrial nucleoid-derived DNA — mechanistic framing, no new sensing assays. [expert-opinion] (novelty: 3)
- 2026-07-14 — TRF2 enriched cytoplasmic chromatin drives cGAS-STAT1-mediated inflammation in senescence.: 2026 preclinical senescence study identifies TRF2-enriched cytoplasmic chromatin fragments as a distinct nuclear-derived DNA ligand engaging cGAS and driving STAT1-mediated SASP; metformin or JAK–STAT inhibition suppresses the axis in cell/mouse models, adding a telomere-protein-marked cytosolic DNA species to the known cGAS substrate repertoire. [animal-model] (novelty: 3)
- 2026-08-17 — Microglia activation by derepression of endogenous retroviruses drives inflammation and cellular senescence.: cross-connection with rte-heterochromatin-derepression: Derepressed retroelement transcripts/reverse-transcribed DNA are candidate ligands for cytosolic nucleic acid sensing, plausibly feeding the interferon arm of the microglial senescence phenotype (linkage inferred, not tested here). (novelty: 3)
- 2026-08-25 — LMNA R527C pathogenic variant causes an inflammation-driven segmental progeroid syndrome via triggering DNA-sensing pathways.: 2026 patient-derived MSC + mouse study: homozygous LMNA R527C disrupts Lamin A–DNA-binding protein interactions and hyperactivates cGAS–STING; genetic or pharmacologic pathway blockade rescues senescence and premature aging phenotypes, pinning a specific laminopathy to DNA-sensing–driven inflammaging. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
The neuro-inflammaging triangle: a self-amplifying circuit of protein pathology, senescence-associated secretory phenotype and innate immunity in neurodegenerative disease.
10-nov-2026
novelty 3
per-area 3
strengthens
When genomes burn: how DNA damage ignites inflammation and fuels ageing.
01-nov-2026
novelty 2
per-area 2
strengthens
Multimodal Technology-Driven aging Research: Decoding the Mitochondria‒Pyroptosis axis in muscle atrophy and cognitive decline.
06-oct-2026
novelty 3
per-area 3
strengthens
Fight Aging! Newsletter, September 28th 2026
27-sep-2026
novelty 2
per-area 3
strengthens
cGAS Knockout Reduces Cellular Senescence in Aged Killifish, But Does Not Extend Life
23-sep-2026
novelty 2
per-area 2
strengthens
Immunosenescence in Uveitis: From Mechanistic Insights to Therapeutic Implications.
22-sep-2026
novelty 2
per-area 2
mentions
Zuogui Pill alleviates chemotherapy-induced ovarian aging and oogonial stem cell injury by modulating cGAS-STING-mediated inflammatory signaling.
19-sep-2026
novelty 2
per-area 3
strengthens
The double-edged sentinel: cGAS-STING as a context-dependent regulator of microglial senescence and neuronal genotoxic stress in neurodegeneration.
16-sep-2026
novelty 2
per-area 3
strengthens
The dimorphic brain in ischemic stroke: How sex and age shape molecular pathophysiology and therapeutic responsiveness.
16-sep-2026
novelty 2
per-area 2
strengthens
Multidimensional Regulatory Network of Cellular Senescence: From Mechanisms to Theranostics.
15-sep-2026
novelty 2
per-area 2
strengthens
MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.
14-sep-2026
novelty 3
per-area 3
strengthens
LAPTM5 correlates with RPE senescence and subretinal fibrosis through the LAPTM5-WWP2-OPTN mitophagy cascade and cGAS/STING activation in a D-galactose-induced aging model.
08-sep-2026
novelty 3
per-area 3
strengthens
From mitochondria to innate immunity: The mtDNA-driven cGAS/STING-NLRP3 cascade and its therapeutic implications in neurodegenerative diseases (Review).
04-sep-2026
novelty 2
per-area 3
strengthens
NADMetabolic Reprogramming Drives CD8T Cells Senescence and Exacerbates Ulcerative Colitis.
01-sep-2026
novelty 3
per-area 3
strengthens
LMNA R527C pathogenic variant causes an inflammation-driven segmental progeroid syndrome via triggering DNA-sensing pathways.
25-aug-2026
novelty 3
per-area 3
strengthens
Spatial niche remodeling of senescent liver-resident immune cells and its role in chronic liver diseases.
18-aug-2026
novelty 3
per-area 3
strengthens
High-fructose diet-induced gut dysbiosis as a mechanistic driver of chronic inflammation and accelerated biological aging: a comprehensive review.
13-aug-2026
novelty 2
per-area 2
strengthens
Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.
07-aug-2026
novelty 2
per-area 2
mentions
The dual role of the cGAS-STING signaling pathway in kidney diseases: from acute injury to chronic fibrosis - molecular mechanisms and precision therapeutic strategies.
05-aug-2026
novelty 2
per-area 3
strengthens
Senomorphic agents: Multi-target strategies to tame the senescence-associated secretory phenotype for healthy ageing.
24-jul-2026
novelty 2
per-area 2
strengthens
Neurovascular unit senescence as a driver of blood-brain barrier dysfunction in Alzheimer's disease:Mechanisms, consequences, and therapeutic implications.
18-jul-2026
novelty 2
per-area 3
strengthens
Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer's and Parkinson's disease.
17-jul-2026
novelty 3
per-area 3
strengthens
Manganese overload as a previously underappreciated trigger of cellular senescence: Unraveling mechanisms and therapeutic rescue by the senolytic quercetin.
17-jul-2026
novelty 3
per-area 3
strengthens
Age-associated decline of Lamtor5 drives immunosenescence and systemic aging via cGAS-mediated paracrine inflammation.
16-jul-2026
novelty 3
per-area 3
strengthens
TRF2 enriched cytoplasmic chromatin drives cGAS-STAT1-mediated inflammation in senescence.
14-jul-2026
novelty 3
per-area 3
strengthens
Aging-driven metabolic abnormalities remodel intercellular communication through the gut-liver-heart axis and may promote coronary artery disease: the key role of bile acid metabolism.
06-jul-2026
novelty 2
per-area 2
strengthens
Co-exposure to environmental lead and hypertension exacerbates anxiety and depression via mtDNA-mediated cGAS phase separation.
27-jun-2026
novelty 3
per-area 3
strengthens
Mitochondrial transcription factor A: linking mtDNA maintenance, mitochondrial stress responses, and inflammaging.
24-jun-2026
novelty 3
per-area 3
strengthens
Jintiange ameliorates age-related sarcopenia by inhibiting the cGAS-STING signaling pathway via maintaining mitochondrial homeostasis.
15-may-2026
novelty 3
per-area 3
strengthens